Dextromethorphan and guaifenesin use need to be monitored diligently in sufferers with "poor metabolizer" CYP2D6 enzyme amounts and patients who're sedated. This mix medication contains a significant median harmful dose (TD50) to median efficient dose (ED50) ratio (or therapeutic index) in these patients. The abuse potential for DXM is a https://chemicalglobe.com/product-tag/dxm-for-sale-near-me/